Mannheim/Germany. Molzym presents a revolutionary broad-spectrum test for Sepsis diagnostics at the 2008 DGKL Congress. This year’s congress of the German United Society of Clinical Chemistry and Laboratory Medicine takes place in Mannheim (Germany) on September 21-24. The Congress and several satellite symposia focus on the role of laboratory diagnostics as a medical core competence in research and patient care.

Update yourself with the latest clinical data on sepsis diagnostic and pass by booth 14.

About SepsiTest™

SepsiTest™ is the first PCR-based broad-spectrum sepsis test enabling routine sepsis screening of bacterial and yeast infections. SepsiTest™ combines all advantages of molecular biology for reliable pathogen detection in blood and other body fluids. SepsiTest™ delivers results in less than 4 hours. SepsiTest™ broad-spectrum molecular diagnostics enable specific rapid sepsis treatment and therapy monitoring.